JOHN R MOORE

CIK 1191702 · General Counsel · last filed 2025-08-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$355.8K

Companies

2

Total Filings

53

Lifetime Open-Market Net

-$4.23M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EWTX General Counsel 10,214 $34.83 $355.8K -$4.23M 23 2025-08-14
ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted Director $0 2 2016-09-14

Recent Filings · Page 3 of 6

53 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-01-25 EWTX Exer (M) +5,400 $3.8K EDGAR
2021-12-30 EWTX Exer (M) +5,400 $3.8K EDGAR
2021-08-19 EWTX Grant (A) $0 EDGAR
2017-04-06 Tax (F) −6,370 -$56.9K
2017-04-04 Mixed +2,310 -$39.4K
2016-12-29 Grant (A) $0
2016-09-14 ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted Grant (A) $0 EDGAR
2016-04-05 Mixed −2,505 -$7.5K
2015-09-15 ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted Grant (A) $0 EDGAR
2015-04-03 Grant (A) +26,875 $0
Showing 2130 of 53
Page 3 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.